Physician profile
Seth A Gordon
NPI 1780091280
$2,346.07
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,304 · 2022: $17.79 · 2024: $24.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $393.99 | 2021 | |
| Amarin Pharma, INC. | $363.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $287.28 | 2021 | |
| Boston Scientific Corporation | $240.19 | 2021-2022 | |
| Esperion Therapeutics, INC. | $149.00 | 2021 | |
| Novo Nordisk INC | $136.52 | 2021 | |
| Amgen INC. | $115.13 | 2021 | |
| Glaxosmithkline, LLC. | $103.82 | 2021 | |
| Lilly USA, LLC | $95.08 | 2021 | |
| Redhill Biopharma INC. | $85.33 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $84.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $78.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.39 | 2021 | |
| Nestle Healthcare Nutrition INC. | $36.64 | 2021 | |
| Merck Sharp & Dohme LLC | $35.68 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.59 | 2024 | |
| Csl Behring | $22.62 | 2021 | |
| Abbvie INC. | $21.66 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.